Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Johnny, what will you say to Tim after he receives his first FDA approval and the PPS spikes to $1 ?
Unfortunately the IRS only permits 3K write-off per year.
RVVTF has gotten hammered too. They thought they had a covid pill, but the FDA said... 'not so fast'. And there goes their PPS. It wasn't too long ago and they were sitting at 40 cents.
I read it the same way. I was hanging my hat on the EUA. The O/S is grossly toooooo high for a company that has never made a profit. I've always known the O/S was a major risk. So I can't blame the company. I knew what I was getting into. Even if they manage to get to the NASDAQ I don't see how that will help the investors without some great news. I don't believe that the profits from the ACE drug sales will be enough to make a dent. Manage gets their high salaries and stock options on the back of the common shareholders. I'm afraid that more dilution is inevitable and we'll see yet another R/S. Once they do one, the next one is easy. Just being honest here. It would take some major news either on the FDA front or on the revenue front to turn this around. There is always the chance for great news. But if that were the case, WHY are they preparing us for more dilution per the recent PR. I queried this on the www............
Is an increase in share capital good or bad?
An increase in the total capital stock showing on a company's balance sheet is usually bad news for stockholders because it represents the issuance of additional stock shares, which dilute the value of investors' existing shares.
RELIEF THERAPEUTICS Holding SA Announces Notice of Annual General Meeting of Shareholders
https://relieftherapeutics.com/newsblog-detail/?newsID=2520845
Yaaa, like news that their subsideary ACER will soon start generating profits off of their new FDA approved drug.
I had iHUB fix the ticker. Now the PPS is correct.
Are you shorting this stock?
BBWolf...might the trial be listed somewhere on this NIH site? I haven't found it, but I may not be looking in the right place. https://clinicalstudies.info.nih.gov/
To be clear..... (PR excerpt):
....the DSMB recommended that the Study be halted early due to statistical significance of the primary endpoint likely NOT going to be met,....
The fat lady has sung. RVVTF now joins the graveyard along with RLFTF and many other biotechs attempting to profit off of COVID. IMO RVV has always been about shrooms anyhow. By his own actions, the CEO has made that clear from day one. I'm sorry for everyone's losses. I took some losses too, but fortunately I exited about the time RLFTF sunk, so I only took a small hit. I predict that within 1-12 months we'll see an R/S (just like what happened to RLFTF). RVVTF is an unprofitable company, and they will need cash to keep afloat. Unfortunately, small foreign biotechs (in this case Swiss and Canadian) have never been on the FDA radar screen IMO. GLTA.
"Averaging Down" is a common tool investors use that gets them into trouble after falling in love with their investments. WE have all been victims of that.
My question is --- if the trial is a failure, will the pps fall further. Or is failure already baked into the current price.
I've always felt that the CEO had fallen in love with his shrooms, and never really gave much priority to Bucillamine as a covid therapy. He had plenty of time to prepare for an FDA green light to proceed, and instead he dragged his feet early on. He did not have his ducks in a row for launching a covid trial. That was my red flag. And the FDA is no longer under pressure to approve EUA applications for covid. Slow you blow, snooze you loose.
A lot of profit taking going on now. There will be volatility as we get closer to the EPS report on May 10.
I missed the boat on this one. I received a very strong insider buy signal but I didn't see it for over 2 weeks.
Pacific Founders Ugp ....Chicago
"INSIDER 4/6/23 BUY $5.5 M at $1.18"
I'm very impressed with the detailed communication to SH !
This has ALWAYS been about COVID and obtaining EUA for Bucillamine. Everything else is pretty much a joke IMO. And the need for a new COVID treatment has dramatically subsided....I'm sorry to say. There are lots of 'once promising' COVID small biotechs in the COVID graveyard now.
Getting to the NASDAQ will have zero benefit for the SH if the company doesn't have a viable product or service for sale. Lots of wannabes on the NASDAQ that get kicked back to the OTC for that reason. So, unless RAM has some other rabbit up his sleeve, r/s'ing to get to the NASDAQ will be a waste of time and money, and the experiment will cost the SH dearly. This will be RAM's opportunity to 'shine or fail miserably'.
Good question.
They need to stop talking about acquiring and expanding, and start PRing their intentions on generating revenues/profits. Enough is enough. I'm afraid the r/s will simply give them an excuse to keep spending and acquiring with no regard for the SH. Rinse, Repeat.
I don't trust mgmt. They tried to hide the r/s. They only reported it in the SEC documents because they had to. So I can only swing trade this (at best).
what is his alias?
Looking back, I'm sure glad I exited this at 3 bucks after the r/s. An r/s is never good for any investor 98% of the time. Mgmt never issued a PR on the r/s because they didn't want to draw attention to it. That was my red flag!
It appears that today's volume is almost 2x that of its 21 day average volume. Can't find any news to justify this pull back. Could be heavy insider dumping ahead of some bad news. Just don't know.
Once the fda approves the trial we should see it on the site.
Phase 3 trial not yet approved. It’s just an application to the fda. Patience.
I think I remember reading something about this some time back. Personally I think what is more important to investors today are current events. IMO there is not a lot to be optimistic about 'today' due to the upcoming R/S. Even if they make it to the NASDAQ, continued dilution will still crush the pps post R/S. I'm afraid that I've lost my trust in RAM and the RLFTF BOD. IMO RAM and the team are still too focused on expanding and creating new ventures than on turning the corner and focusing on generating revenues.
Tractor... a VERY long hold. Years imo !
It's called corporate restructuring. Why would Tim care about that 400M shares if in the meantime he has generated millions of $$ via dilution. He got what he wanted. The 400M could be simply symbolic. Also, he will simply issue himself another 400,000,000 shares in the 'new' corporate entity. He will have a social issue though if he persuaded his family and friends into buying a large quantity of shares in TSOI. The SEC simply doesn't have the resources to go after 'ethics' violations in sub-penny stocks on the OTC. Investing in TSOI requires trusting Tim. -- technically TSOI is not on the normal OTC. It's on the pink sheets referred to as "Other OTC". This is barely on the SEC radar screen.
Well, I do FEAR that when Tim is capable of marketing his patents (may take a few years), that he will dissolve this corporate entity making existing shares worthless. Then he will set up a new corporate entity from scratch to 'launch' his new business. Hence, he will make good on his promise to never R/S TSOI. I think there is a high probability that this has been Tim's long-term strategy all along.....so, I never allowed myself to put too much skin in this game. My risk is very low. The grossly high O/S and Float are the major red flags.
But one never really knows. Maybe Tim will surprise everyone in 2025 or 2026 and sell out to the highest bidder and then we all get paid.
If the SEC investigates TSOI and concludes that illegal activity has occurred (whether intentional or not), that could result in the SEC delisting TSOI. We would not want that since that would essentially make all shares of TSOI worthless (not good for incumbent investors !!). It is far wiser to let the winds sail this ship where it may, and hope that something good comes out of it in the end. Delisting by the SEC will wipe out the little equity one currently has.
Rick.. one could argue that Mike may have hired the wrong outfit to conduct the trial. He may have been trying to safe $$. This is exactly what RLFTF did. They hired an outfit that bungled everything up on the end-points.
It would seem to me that RLFTF needs to NOW focus on generating sales and turning a profit off of their existing portfolio of drugs. Rather than pay more salaries and bonuses for more R&D in gene therapy. Where are the $$ going to come from to pay this person. Is RAM's vision a never ending black hole of R&D. It's time to start generating sales and moving toward a profit making enterprise. They are about to do an R/S, and we know where that will take us a year down the road. More dilution to pay for initiatives such as this. JMHO.
Investing in penny stocks is a HIGH RISK decision. Some decisions work out, but many/most are bad decisions in the penny stock space. The SEC has stated that time and time again. The SEC warns the public to stay away from penny stocks unless the risk is acceptable. No one forced anyone to buy QNTA. It's a conscience, decision making process. Accepting the 'high' risk and the consequences of failure is on the investor. To avoid risk, buy CDs. QNTA is not dead just yet. They may still be able to pull a rabbit out of their hat.
How?
It doesn't matter if one is right or wrong. Grieving over a bad decision doesn't solve anything either. Especially when there are lots of other opportunities out there.
They also did not issue a PR immediately preceding the r/s. Which IMO is a total disregard for the SH. Having said that, I realize that many investors here have posted that the lack of a PR is a non-issue. For me though it is an issue. It says something about managements respect for the SH. But it is what it is.
Yes, that is true too. However, a lot of SH don't understand even the structural basics of the r/s because they haven't experienced it yet. Often they are sold a bill of goods by insiders claiming the r/s is used to uplist to the NASDAQ...which often is b.s. IMO ease of dilution to raise $ to pay the bills (salaries) is usually the primary insider goal of an r/s. Ease of price and spread manipulation by market makers is a whole nuther convoluted world -- as you pointed out. I have rarely ever seen a good thing occur from an r/s. It appears that a lot of longs lost a good chunk of equity here after this r/s occurred. I now exit any penny stock position once it becomes clear that an r/s is about to hit the books (which included this one). I view it as risk management.
Mountain, I don't think we will see any PR news until they have something 'real' to say. I'm sure they are paranoid that the SEC is watching what they say to their investors. So I expect long periods of radio silence. We may not hear anything until much later in the year IMO.
Meanwhile, I'm proactively swing trading elsewhere. No sense in grieving over this stock when everything is out of our control. I say..... make money elsewhere, while you wait for this to turn around (if it turns around).